The Great New Zealand Trek has raised almost a quarter of a million dollars to support our Multiple Sclerosis research

28 February 2017, Multiple Sclerosis, Professor Anne La Flamme, Supporting the Malaghan Institute

Over the last 8 years, The Great New Zealand Trek has donated $245,000 to help find a cure for Multiple Sclerosis – a truly incredible achievement. We are more than grateful for this tremendous and sustained support of our research.

The 2017 Trek will travel the length of New Zealand with trekkers walking, biking or horse riding. With off road access, en route support, luggage transport, camping and yarding, professional caterers, hot showers, massage, live entertainment, bar, café and a huge support crew, it is much more than a trek, it is luxury travel.

 

 

Stage 12 – 4th to 12th March 2017

Stage 12’s Great NZ Trek will take you to the South Island and into the heart of Central Otago. Starting in the Burkes Pass area just west of Fairlie, heading South crossing over the Ohau C power station at the top of Lake Benmore and then down to Omarama for a rest day. After the rest day, Trek continues South over the Omarama saddle to Saint Bathans, an old mining town alongside Blue Lake and the Vulcan Hotel. From Saint Bathans, there will be a final trek to Becks, where you can find the historic White Horse Hotel on the road to Alexandra. The routes will showcase the beautiful South Island and be sure to have plenty of variation in the terrain.

You can sign up directly on The Great New Zealand Trek website.

This charity is committed to find a cure for Multiple Sclerosis as it is the most common central nervous system disease among young adults in New Zealand.

Since 2009 the charitable trust has been supporting our Multiple Sclerosis research programme, led by Professor Anne La Flamme, who says: “Our research is only made possible by generous donations from the Great New Zealand Trek, who have provided sustained and generous funding over the past 7 years. These funds have enabled us to identify promising treatments for progressive multiple sclerosis and to uncover unexpected aspects of this devastating disease. We are grateful for their generosity and trust.”